Cardiovascular Effects of COVID-19: Acute and Chronic
A special issue of COVID (ISSN 2673-8112). This special issue belongs to the section "COVID Clinical Manifestations and Management".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 24
Special Issue Editor
Special Issue Information
Dear Colleagues,
COVID had a significant impact on patients with cardiovascular disease as well as the entire cardiovascular community. The direct effects of COVID on acute coronary syndromes including STEMI and thrombotic complications including DVT’s, pulmonary embolism as well as microvascular thrombi that occurred in multiple vascular distributions have been well documented. The cardiovascular community was also impacted by the indirect effects which included the public health measures implemented which resulted in hospital avoidance, decreases in compliance with cardiovascular medications and reduction in cardiovascular testing and procedures that was quite dramatic. While many of these direct and indirect effects of COVID have improved, we continue to see the impact in patients with long COVID, a complex syndrome with components of both inflammation and microvascular dysfunction. In this special issue we will highlight both the acute and the chronic effects of COVID on cardiovascular disease.
Dr. Timothy D. Henry
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. COVID is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microthrombi
- STEMI
- long COVID
- COVID related acute coronary syndromes
- cardiovascular effects of COVID
- biology
- immune response
- genetics
- endothelial health
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
